These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 10407781)

  • 41. Carnitine deficiency disorders in children.
    Stanley CA
    Ann N Y Acad Sci; 2004 Nov; 1033():42-51. PubMed ID: 15591002
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical manifestations and management of fatty acid oxidation disorders.
    Merritt JL; MacLeod E; Jurecka A; Hainline B
    Rev Endocr Metab Disord; 2020 Dec; 21(4):479-493. PubMed ID: 32654032
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fatty acid oxidation defects presenting as primary myopathy and prominent dropped head syndrome.
    Vengalil S; Preethish-Kumar V; Polavarapu K; Christopher R; Gayathri N; Natarajan A; Manjunath M; Nashi S; Prasad C; Nalini A
    Neuromuscul Disord; 2017 Nov; 27(11):986-996. PubMed ID: 28927828
    [TBL] [Abstract][Full Text] [Related]  

  • 44. New developments in the diagnosis and investigation of mitochondrial fatty acid oxidation disorders.
    Coates PM
    Eur J Pediatr; 1994; 153(7 Suppl 1):S49-56. PubMed ID: 7957387
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Defects in activation and transport of fatty acids.
    Brivet M; Boutron A; Slama A; Costa C; Thuillier L; Demaugre F; Rabier D; Saudubray JM; Bonnefont JP
    J Inherit Metab Dis; 1999 Jun; 22(4):428-41. PubMed ID: 10407779
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years.
    Lundemose JB; Kølvraa S; Gregersen N; Christensen E; Gregersen M
    Mol Pathol; 1997 Aug; 50(4):212-7. PubMed ID: 9350306
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term major clinical outcomes in patients with long chain fatty acid oxidation disorders before and after transition to triheptanoin treatment--A retrospective chart review.
    Vockley J; Marsden D; McCracken E; DeWard S; Barone A; Hsu K; Kakkis E
    Mol Genet Metab; 2015; 116(1-2):53-60. PubMed ID: 26116311
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Diagnostic approach and treatment of inherited mitochondrial fatty acid oxidation disorders].
    Peña Quintana L; Sanjurjo Crespo P
    An Esp Pediatr; 2001 Dec; 55(6):524-34. PubMed ID: 11730586
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile.
    Rashed MS; Ozand PT; Bennett MJ; Barnard JJ; Govindaraju DR; Rinaldo P
    Clin Chem; 1995 Aug; 41(8 Pt 1):1109-14. PubMed ID: 7628085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response.
    Vatanavicharn N; Yamada K; Aoyama Y; Fukao T; Densupsoontorn N; Jirapinyo P; Sathienkijkanchai A; Yamaguchi S; Wasant P
    Brain Dev; 2015 Aug; 37(7):698-703. PubMed ID: 25459972
    [TBL] [Abstract][Full Text] [Related]  

  • 51. UX007 for the treatment of long chain-fatty acid oxidation disorders: Safety and efficacy in children and adults following 24weeks of treatment.
    Vockley J; Burton B; Berry GT; Longo N; Phillips J; Sanchez-Valle A; Tanpaiboon P; Grunewald S; Murphy E; Humphrey R; Mayhew J; Bowden A; Zhang L; Cataldo J; Marsden DL; Kakkis E
    Mol Genet Metab; 2017 Apr; 120(4):370-377. PubMed ID: 28189603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bile acylcarnitine profiles in pediatric liver disease do not interfere with the diagnosis of long-chain fatty acid oxidation defects.
    Fuda F; Narayan SB; Squires RH; Bennett MJ
    Clin Chim Acta; 2006 May; 367(1-2):185-8. PubMed ID: 16414039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neonatal metabolic myopathies.
    Tein I
    Semin Perinatol; 1999 Apr; 23(2):125-51. PubMed ID: 10331465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vivo stable isotope studies in three patients affected with mitochondrial fatty acid oxidation disorders: limited diagnostic use of 1-13C fatty acid breath test using bolus technique.
    Jakobs C; Kneer J; Martin D; Boulloche J; Brivet M; Poll-The BT; Saudubray JM
    Eur J Pediatr; 1997 Aug; 156 Suppl 1():S78-82. PubMed ID: 9266222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differences between acylcarnitine profiles in plasma and bloodspots.
    de Sain-van der Velden MG; Diekman EF; Jans JJ; van der Ham M; Prinsen BH; Visser G; Verhoeven-Duif NM
    Mol Genet Metab; 2013; 110(1-2):116-21. PubMed ID: 23639448
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hypoglycaemia without ketosis. A case report].
    Ferraz C; Reis ME; Lopes MM; Cardoso ML; Barbosa CR
    Rev Neurol; 2005 Sep 16-30; 41(6):349-53. PubMed ID: 16163656
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Metabolic encephalopathy in Egyptian children.
    Hindawy A; Gouda A; El-Ayyadi A; Megahed H; Bazaraa H
    Bratisl Lek Listy; 2007; 108(2):75-82. PubMed ID: 17685006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Food withdrawal lowers energy expenditure and induces inactivity in long-chain fatty acid oxidation-deficient mouse models.
    Diekman EF; van Weeghel M; Wanders RJ; Visser G; Houten SM
    FASEB J; 2014 Jul; 28(7):2891-900. PubMed ID: 24648546
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of heat stress and bezafibrate on mitochondrial beta-oxidation: comparison between cultured cells from normal and mitochondrial fatty acid oxidation disorder children using in vitro probe acylcarnitine profiling assay.
    Li H; Fukuda S; Hasegawa Y; Kobayashi H; Purevsuren J; Mushimoto Y; Yamaguchi S
    Brain Dev; 2010 May; 32(5):362-70. PubMed ID: 19589653
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A retrospective ESI-MS/MS analysis of newborn blood spots from 18 symptomatic patients with organic acid and fatty acid oxidation disorders diagnosed either in infancy or in childhood.
    Kobayashi H; Hasegawa Y; Endo M; Purevsuren J; Yamaguchi S
    J Inherit Metab Dis; 2007 Aug; 30(4):606. PubMed ID: 17641825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.